(Q46416734)

22 December 2017

title

A mathematical model for the administration of temozolomide: comparative analysis of conventional and metronomic chemotherapy regimens (English)

1 reference

22 December 2017

main subject

temozolomide

1 reference

ChEBI release 2020-05-28

1 reference

3

1 reference

22 December 2017

author name string

C Faivre

series ordinal

1

1 reference

22 December 2017

D Barbolosi

series ordinal

2

1 reference

22 December 2017

N André

series ordinal

4

1 reference

22 December 2017

publication date

7 February 2013

1 reference

22 December 2017

Cancer Chemotherapy and Pharmacology

published in

1 reference

22 December 2017

volume

71

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

1013-1019

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1007/s00280-013-2095-z

exact match

0 references

cites work

Combining temozolomide with other antitumor drugs and target-based agents in the treatment of brain metastases: an unending quest or chasing a chimera?

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2095-Z

Pilot study of a pediatric metronomic 4-drug regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2095-Z

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2095-Z

On the Nature of the Function Expressive of the Law of Human Mortality, and on a New Mode of Determining the Value of Life Contingencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2095-Z

Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2095-Z

Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2095-Z

Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2095-Z

Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2095-Z

The anti-angiogenic basis of metronomic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2095-Z

Nontoxic, fiscally responsible, future of oncology: could it be beginning in the Third World?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2095-Z

Inhibition of angiogenesis by non-toxic doses of temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2095-Z

Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2095-Z

An interface model for dosage adjustment connects hematotoxicity to pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2095-Z

Redefining the target: chemotherapeutics as antiangiogenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2095-Z

Chemoresistance to temozolomide in human glioma cell line U251 is associated with increased activity of O6-methylguanine-DNA methyltransferase and can be overcome by metronomic temozolomide regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2095-Z

Population pharmacokinetics of temozolomide and metabolites in infants and children with primary central nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2095-Z

Metronomic chemotherapy: new rationale for new directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2095-Z

Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2095-Z

Paclitaxel at ultra low concentrations inhibits angiogenesis without affecting cellular microtubule assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2095-Z

Preclinical pharmacokinetic and pharmacodynamic evaluation of metronomic and conventional temozolomide dosing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2095-Z

Metronomic chemotherapy with the COMBAT regimen in advanced pediatric malignancies: a multicenter experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2095-Z

10.1007/S00280-013-2095-Z

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017